Nauman Shah, Johnson & Johnson: «We Don’t Pursue Me-Toos»

Episode 4 of 𝗕𝗜𝗢 & 𝗕𝗲𝘆𝗼𝗻𝗱: 𝗖𝗵𝗶𝗻𝗮 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗚𝗼𝗲𝘀 𝗚𝗹𝗼𝗯𝗮𝗹. Nauman Shah, Global Head of Innovative Medicine Business Development at Johnson & Johnson, leads the strategy behind J&J’s acquisitions, licensing and partnerships across oncology, immunology, neuroscience and beyond. In this conversation, he explains how J&J sources innovation, why it looks only for transformational science, what the Carvykti partnership with Legend shows about China-origin assets, and how AI is changing BD and innovation scouting. Chapters: 0:00 Introduction 0:44 The role of BD in J&J’s strategy 2:02 Telling true innovation from me-too followers 3:59 China as a source of innovation 5:43 AI in BD and innovation scouting 6:56 Closing remarks Subscribe for more episodes of the series. #BIOandBeyond #ChinaBiopharma #BusinessDevelopment #JohnsonAndJohnson #Biotech #PharmaBD